ArticleCell reports2015

Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.

Jing Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.